Michelle Werner
Direktor/Vorstandsmitglied bei OMEGA THERAPEUTICS, INC.
Vermögen: - $ am 30.04.2024
Profil
Michelle C.
Werner is currently the CEO-Partner at Flagship Pioneering, the Chief Executive Officer at Alltrna, and the Director at Omega Therapeutics, Inc. She previously worked as a Director at Channel One, Inc., the US Brand Lead for Reyataz at Bristol Myers Squibb Co. from 2014 to 2015, and as the VP & Head-Global Haematology Franchise at AstraZeneca PLC in 2020.
Ms. Werner received her undergraduate degree from the University of Pennsylvania in 1997 and her MBA from the London Business School in 2005.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OMEGA THERAPEUTICS, INC.
-.--% | 28.08.2023 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Michelle Werner
| Unternehmen | Position | Beginn |
|---|---|---|
| OMEGA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 28.08.2023 |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 01.04.2022 |
Alltrna
 Alltrna BiotechnologyHealth Technology Alltrna is a biotech company that uses AI/ML tools to learn the language of tRNA and develop programmable molecules with therapeutic potential. Alltrna was founded in 2018 by Flagship Pioneering and is based in Cambridge, MA. The company aims to correct diseases by advancing a single tRNA medicine to treat a wide range of diseases with the same underlying genetic mutation. The company's CEOs are Michelle C. Werner and Lovisa Afzelius. | Vorstandsvorsitzender | 01.04.2022 |
Ehemalige bekannte Positionen von Michelle Werner
| Unternehmen | Position | Ende |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 02.07.2020 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 02.05.2015 |
Channel One, Inc.
 Channel One, Inc. Services to the Health IndustryHealth Services Channel One, Inc. functions as a non-profit organization that offers programs that help feed people in need and that reduce waste. It operates a food bank, a food shelf, and a green garden as well as organize a commodity supplemental food program. The company was founded in February 1980 and is headquartered in Rochester, MN. | Direktor/Vorstandsmitglied | - |
Ausbildung von Michelle Werner
| London Business School | Masters Business Admin |
| University of Pennsylvania | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| OMEGA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Channel One, Inc.
Channel One, Inc. Services to the Health IndustryHealth Services Channel One, Inc. functions as a non-profit organization that offers programs that help feed people in need and that reduce waste. It operates a food bank, a food shelf, and a green garden as well as organize a commodity supplemental food program. The company was founded in February 1980 and is headquartered in Rochester, MN. | Health Services |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Alltrna
Alltrna BiotechnologyHealth Technology Alltrna is a biotech company that uses AI/ML tools to learn the language of tRNA and develop programmable molecules with therapeutic potential. Alltrna was founded in 2018 by Flagship Pioneering and is based in Cambridge, MA. The company aims to correct diseases by advancing a single tRNA medicine to treat a wide range of diseases with the same underlying genetic mutation. The company's CEOs are Michelle C. Werner and Lovisa Afzelius. | Health Technology |
